During the past decade, Krankenhaus Waldfriede e. V. conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 13 clinical trials were completed, i.e. on average, 44.8% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 12 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Krankenhaus Waldfriede e. V." #1 sponsor was "Takeda" with 6 trials, followed by "Celgene" with 5 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored and "Pfizer" with 3 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Krankenhaus Waldfriede e. V." #1 collaborator was "Takeda Development Center Americas, Inc." with 2 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Cook Biotech Incorporated" with 1 trials as a collaborator, "Cook Ireland, Ltd." with 1 trials as a collaborator and "German Federal Ministry of Education and Research" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Krankenhaus Waldfriede e. V." are "Crohn Disease" (9 trials), "Ulcerative Colitis" (9 trials), "Crohn's Disease" (6 trials), "Colitis, Ulcerative" (3 trials) and "Anal Fistula" (1 trials). Many other conditions were trialed in "Krankenhaus Waldfriede e. V." in a lesser frequency.

Most popular intervention types in "Krankenhaus Waldfriede e. V." are "Drug" (25 trials), "Other" (5 trials), "Device" (4 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Etrolizumab" (4 trials), "Etrasimod" (3 trials), "Ozanimod" (3 trials) and "GED-0301" (2 trials). Other intervention names were less common.

The vast majority of trials in "Krankenhaus Waldfriede e. V." are 31 trials for "All" genders.

Currently, there are NaN active trials in "Krankenhaus Waldfriede e. V.". undefined are not yet recruiting, 11 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Krankenhaus Waldfriede e. V., undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Krankenhaus Waldfriede e. V., 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".